Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1979)	10/3/2000 12:05:57 AM
From: scaram(o)uche	Respond to of 4974

Monday October 2, 10:48 pm Eastern Time Press Release SOURCE: Ciphergen Biosystems, Inc. Ciphergen Announces Exercise of Over-Allotment Option FREMONT, Calif., Oct. 2 /PRNewswire/ -- Ciphergen Biosystems, Inc. (Nasdaq: CIPH - news) today announced that the underwriters have exercised in full their over-allotment option in connection with Ciphergen's initial public offering, and purchased an additional 825,000 shares of Ciphergen's common stock at the initial offering price of $16 per share, less underwriting discounts and commissions. After giving effect to the sale of these shares, a total of 6,325,000 shares of common stock were offered and sold in the offering, raising gross proceeds for the company of $101.2 million before underwriting discounts, commissions and other offering expenses. (snip)